- Home
- ROIV vs CMA Comparison
ROIV vs CMA Comparison
Compare ROIV & CMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- CMA
- Stock Information
- Founded
- ROIV 2014
- CMA 1849
- Country
- ROIV United Kingdom
- CMA United States
- Employees
- ROIV N/A
- CMA N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- CMA Major Banks
- Sector
- ROIV Health Care
- CMA Finance
- Exchange
- ROIV Nasdaq
- CMA Nasdaq
- Market Cap
- ROIV 8.4B
- CMA 7.1B
- IPO Year
- ROIV N/A
- CMA N/A
- Fundamental
- Price
- ROIV $10.79
- CMA $58.81
- Analyst Decision
- ROIV Buy
- CMA Hold
- Analyst Count
- ROIV 4
- CMA 20
- Target Price
- ROIV $17.50
- CMA $62.95
- AVG Volume (30 Days)
- ROIV 5.9M
- CMA 1.5M
- Earning Date
- ROIV 05-29-2025
- CMA 04-21-2025
- Dividend Yield
- ROIV N/A
- CMA 4.83%
- EPS Growth
- ROIV N/A
- CMA 4.95
- EPS
- ROIV N/A
- CMA 5.29
- Revenue
- ROIV $122,585,000.00
- CMA $3,234,000,000.00
- Revenue This Year
- ROIV N/A
- CMA $7.20
- Revenue Next Year
- ROIV N/A
- CMA $3.01
- P/E Ratio
- ROIV N/A
- CMA $11.12
- Revenue Growth
- ROIV 140.04
- CMA N/A
- 52 Week Low
- ROIV $8.73
- CMA $45.32
- 52 Week High
- ROIV $13.06
- CMA $73.45
- Technical
- Relative Strength Index (RSI)
- ROIV 50.06
- CMA 62.43
- Support Level
- ROIV $10.58
- CMA $54.42
- Resistance Level
- ROIV $11.77
- CMA $59.36
- Average True Range (ATR)
- ROIV 0.34
- CMA 1.16
- MACD
- ROIV -0.07
- CMA 0.62
- Stochastic Oscillator
- ROIV 17.65
- CMA 91.83
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About CMA Comerica Incorporated
With assets of around $80 billion, Comerica is primarily a relationship-based commercial bank headquartered in Dallas. In addition to Texas, Comerica's other primary geographies are California and Michigan, with locations also in Arizona and Florida and select businesses operating in several other states as well as Canada and Mexico.